Recombinant multi-species WHSC1/NSD2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WHSC1/NSD2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein that contains four domains present in other developmental proteins: a PWWP domain, an HMG box, a SET domain, and a PHD-type zinc finger. It is expressed ubiquitously in early development. Wolf-Hirschhorn syndrome (WHS) is a malformation syndrome associated with a hemizygous deletion of the distal short arm of chromosome 4. This gene maps to the 165 kb WHS critical region and has also been involved in the chromosomal translocation t(4;14)(p16.3;q32.3) in multiple myelomas. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. Some transcript variants are nonsense-mediated mRNA (NMD) decay candidates, hence not represented as reference sequences. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 5830445G22Rik,9430010A17Rik,C130020C13Rik,D030027O06Rik,D930023B08Rik,Histone-lysine N-methyltransferase NSD2,KMT3F,KMT3G,MMSET,Multiple myeloma SET domain-containing protein (MMSET),NSD2,Nsd2,Nuclear SET domain-containing protein 2,Protein trithorax-5,RAUST,REIIBP,RGD1565590,TRX5,WHS,WHSC1,Whsc1,Whsc1l,Wolf-Hirschhorn syndrome candidate 1 protein,mKIAA1090
Go
to WHSC1/NSD2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP11928-Ag-1/ GM-Tg-hg-IP11928-Ag-2 | Human WHSC1/NSD2 protein | Human |
| GM-Tg-rg-IP11928-Ag-1/ GM-Tg-rg-IP11928-Ag-2 | Rat WHSC1/NSD2 protein | Rat |
| GM-Tg-mg-IP11928-Ag-1/ GM-Tg-mg-IP11928-Ag-2 | Mouse WHSC1/NSD2 protein | Mouse |
| GM-Tg-cynog-IP11928-Ag-1/ GM-Tg-cynog-IP11928-Ag-2 | Cynomolgus/Rhesus macaque WHSC1/NSD2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP11928-Ag-1/ GM-Tg-felg-IP11928-Ag-2 | Feline WHSC1/NSD2 protein | Feline |
| GM-Tg-cang-IP11928-Ag-1/ GM-Tg-cang-IP11928-Ag-2 | Canine WHSC1/NSD2 protein | Canine |
| GM-Tg-bovg-IP11928-Ag-1/ GM-Tg-bovg-IP11928-Ag-2 | Bovine WHSC1/NSD2 protein | Bovine |
| GM-Tg-equg-IP11928-Ag-1/ GM-Tg-equg-IP11928-Ag-2 | Equine WHSC1/NSD2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP11928-Ag-1/ GM-Tg-hg-IP11928-Ag-2;
GM-Tg-rg-IP11928-Ag-1/ GM-Tg-rg-IP11928-Ag-2;
GM-Tg-mg-IP11928-Ag-1/ GM-Tg-mg-IP11928-Ag-2; GM-Tg-cynog-IP11928-Ag-1/ GM-Tg-cynog-IP11928-Ag-2; GM-Tg-felg-IP11928-Ag-1/ GM-Tg-felg-IP11928-Ag-2; GM-Tg-cang-IP11928-Ag-1/ GM-Tg-cang-IP11928-Ag-2; GM-Tg-bovg-IP11928-Ag-1/ GM-Tg-bovg-IP11928-Ag-2; GM-Tg-equg-IP11928-Ag-1/ GM-Tg-equg-IP11928-Ag-2 |
| Products Name | WHSC1/NSD2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | WHSC1/NSD2 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WHSC1/NSD2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.